Systemic sclerosis Flashcards
Define systemic sclerosis
Rare connective tissue disease characterised by
widespread small blood vessel damage and fibrosis in skin and internal organ
Also known as scleroderma
What is Pre-Scleroderma?
Raynaud’s phenomenon
Nail-fold capillary changes
Antinuclear antibodies
What is Diffuse Cutaneous Systemic Sclerosis?
(40%) of Scelroderma
Raynaud’s phenomenon
Followed by skin changes with truncal involvement
Tendon friction
Joint contracture
Early lung disease
Heart, GI and renal disease
Nail-fold capillary dilatation
What is Limited Cutaneous Systemic Sclerosis?
(60%) of Scleroderma
Previously known as CREST Syndrome because of its FIVE characteristic features: Calcinosis Raynaud's phenomenon (O)esophageal dysmotility Sclerodactyly Telangiectasia
What is Scleroderma sine Scleroderma?
Internal organ disease with NO skin changes
Explain the aetiology/risk factors of systemic sclerosis
UNKNOWN
Genetic and environmental factors
Pathogenesis is unclear
Activated monocytes, macrophages and lymphocytes may interact with:
Endothelial cells –> endothelial cell damage, platelet activation, narrowing of blood vessels
Fibroblasts –> lay down collagen in the dermis
Summarise the epidemiology of systemic sclerosis
Age of onset: 30-60 yrs
3 x more common in FEMALES
Recognise the presenting symptoms and signs of systemic sclerosis
Skin - Raynaud’s phenomenon
Hands - Initially swollen painful fingers, Later, they become thickened, tight, shiny and bound to underlying structures. Changes in pigmentation. Finger ulcers
Face - Microstomia (puckering of the skin around the mouth). Telangiectasia.
Lung - pulmonary fibrosis —> pulmonary hypertension
Heart - pericarditis or pericardial effusion, myocardial fibrosis, heart failure, arrhythmias
GI - dry mouth, oesophageal dysmotility, reflux oesophagitis, gastric paresis
Kidneys - hypertensive renal crisis, chronic renal failure
Neuromuscular - trigeminal neuralgia, muscular wasting, weakness
Others - hypothyroidism, impotence
Identify appropriate investigations for systemic sclerosis
Autoantibodies - Antinuclear, Anti-centromere (70% of limited cutaneous systemic sclerosis cases). Anti-topoisomerase II (anti-Scl-70) - 30% of diffuse cutaneous systemic sclerosis cases. Anti-nucleolar. Anti-RNA polymerase
Lungs - CXR, pulmonary function tests, CT scan
Heart - ECG, echocardiography
GI - endoscopy, barium studies
Kidneys - U&Es, creatinine clearance
Neuromuscular - electromyography, biopsy
Joints - radiograph
Skin - biopsy (rarely needed)